Repeated biopsies of brain metastases showed that the tumor tissue contains EGFR suppressors, phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK), and cyclin-dependent kinase pathways, and other potential targets. Here, MTOR is linked to neoplasm.